Wendell S. Fortson, J.D., Ph.D., is the founder and principal of Fortson Strategies, LLC. Dr. Fortson is a cancer biologist who has been researching and studying cancer for nearly 20 years. His industry experience includes employment at the Pharmaceutical Research and Manufacturers of America (PhRMA) as Senior Director of Science and Regulatory Advocacy. Prior to this position, Dr. Fortson was employed at Lundbeck Pharmaceuticals as Associate Director of Regulatory Affairs Strategy and Policy.
Dr. Fortson completed a postdoctoral fellowship at The University of North Carolina at Chapel Hill Schools of Medicine and Law—Center for Genomics and Society. During this fellowship, Dr. Fortson researched, inter alia, the ethical, legal, and social implications of genetic research and pharmacogenomics drug development. Concurrently, while completing his postdoctoral fellowship, Dr. Fortson also pursued and received his juris doctor (J.D.) degree from North Carolina Central University School of Law*.
Prior to his postdoctoral fellowship, Dr. Fortson received his Ph.D. in Biomedical Sciences–Cancer Biology from Morehouse School of Medicine (Click here for a summary of his research). While completing his dissertation research, Dr. Fortson assisted GE Healthcare in optimizing its Amersham CyScribe Array CGH Genomic DNA Labeling System—a system designed to identify chromosomal abnormalities.
Dr. Fortson received his bachelor of science (B.S.) degree in Biology from Tennessee State University. During his senior year, Dr. Fortson researched the apoptotic effects of St. John’s Wort and Echinacea plant extracts on breast cancer cell lines.
Dr. Fortson is an avid supporter of cancer research, notably types of breast cancers that disproportionately affect minority women. He is also passionate about mentoring minority high school, undergraduate and graduate students in personal and professional development.
*[Dr. Fortson is not licensed to practice law.]